US-206 — Grand Rapids, Michigan

US-206 is a clinical research site located in Grand Rapids, Michigan, United States 49546.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

US-206 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Solid Tumor.

Sponsors: MediLink Therapeutics (Suzhou) Co., Ltd..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US-206?

US-206 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US-206 conducted?

US-206 has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor.

Is US-206 accredited by Crixeo Health?

US-206 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US-206?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.